Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Here, a zinc-cystine (Zn-cys) biological-metal-organic framework (bio-MOF) coated with folic acid-modified chitosan (FC) nanogel, was developed for pH/glutathione dual-responsive delivery of doxorubicin (DOX). In vitro drug release demonstrated a superior cumulative DOX release (83.5 %) at pH 5.8 and a high GSH concentration (10 mM). According to the MTT assay, the DOX-loaded Zn-cys bio-MOF/FC showed significant toxicity against MCF-7 cells (positive folate receptor) compared to HUVEC cells (low expressed level of folate receptor), by reducing cancer cell viability to 23.8 ± 0.34 % after 48 h incubation. The cellular uptake study confirmed that Zn-cys bio-MOF/FC could be readily internalized by MCF-7 cells via endocytosis. The results indicated an enhanced apoptosis rate of DOX@Zn-cys bio-MOF/FC (22.8 %) compared to free DOX (6.04 %). Fluorescence microscopy further confirmed higher cell death induced by the DOX@Zn-cys bio-MOF/FC nanocarrier in MCF-7 cells. Hemolysis analysis revealed that the nanocarrier was safe and exhibited no hemolytic activity. According to western blot analysis, DOX@Zn-cys bio-MOF/FC showed effective anti-cancer activity by up-regulating the expression level of Bax (a pro-apoptotic protein) and down-regulating the expression level of Bcl-2 (an anti-apoptotic protein). Therefore, the developed nanocarrier could be a promising candidate for targeted breast cancer therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijbiomac.2025.146459 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Circ_0000437 promotes proliferation, invasion, migration and epithelial-mesenchymal transition of breast cancer cells by targeting the let-7b-5p/CTPS1 axis].
Nan Fang Yi Ke Da Xue Xue Bao
August 2025
College of Laboratory Medicine, Wannan Medical College, Wuhu 241000, China.
Objectives: To investigate the role of circular RNA circ_0000437 in regulating biological behaviors of breast cancer cells and the molecular mechanism.
Methods: Breast cancer MCF-7 and MDA-MB-231 cells were transfected with sh-circ_0000437, mimics, inhibitor, si-CTPS1, or their respective negative controls. qRT-PCR was used to detect the expression levels of circ_0000437, let-7b-5p, CTPS1, Notch1, Hes1, and Numb in breast cancer cell lines and tissues.
Grafting of Resveratrol-Chitosan Nanoparticles as a Promising Radiosensitizer and Protector in DMBA-Induced Breast Cancer in Mice.
Curr Cancer Drug Targets
September 2025
Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Menoufia, Egypt.
Introduction: Breast cancer is the most common malignancy among women and the second leading cause of cancer-related deaths worldwide. Resveratrol, a polyphenolic stilbene derivative found in grapes, red wine, and other plants, possesses anti-cancer properties. Various studies have reported the potential of different nanomaterials to act as radiosensitizers against tumor cells.
View Article and Find Full Text PDFStructural hybridization of alepterolic acid with piperazine-benzamide motifs yields potent anticancer agents.
Bioorg Chem
September 2025
School of Chemistry and Chemical Engineering, Anhui University of Technology, Ma'anshan, PR China. Electronic address:
Among the most pervasive malignancies affecting females worldwide, breast cancer is responsible for approximately 2.2 million new diagnoses and over 660,000 fatalities reported annually. Natural products represent an invaluable resource for the identification and development of potential innovative anti-cancer pharmaceuticals.
View Article and Find Full Text PDFFolic acid conjugated magnetic chitosan nanocomposite for the targeted delivery of dual anticancer drugs to breast cancer and hyperthermia therapy.
Int J Biol Macromol
September 2025
Crystal Growth Centre, Anna University, Chennai, 600025, Tamil Nadu, India.
Increase in breast cancer has led to the search for systems that can enable, targeted, sustained and prolonged release of drugs while simultaneously reducing the side effects posed by them. In light of this, folic acid-conjugated 5-Fluorouracil and doxorubicin loaded chitosan/Fe₃O₄ (FA-dual@CS/Fe₃O₄) nanocomposite has been synthesized using the chemical method for targeted breast cancer therapy in addition to CS/FeO and dual drug encapsulated CS/FeO. FTIR and XPS studies confirm the successful drug encapsulation and FA conjugation.
View Article and Find Full Text PDFChitosan/dialdehyde starch coating onto l-tyrosine and curcumin intercalated layered double hydroxide for improved the therapeutic effects of breast cancer.
Int J Biol Macromol
September 2025
Polymer Research Laboratory, Department of Organic and Biochemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran; Research Center for Pharmaceutical Nanotechnology (RCPN), Biomedicine Institute, Tabriz University of Medical Science, Tabriz, Iran. Electronic address:
This study aimed to develop an innovative pH-sensitive bio-hydrogel containing curcumin (CUR) and l-tyrosine (Tyr) intercalated layered double hydroxide-modified chitosan (CS)/dialdehyde starch (DAS) (DAS-CS@Tyr-CUR@LDH) to facilitate the controlled release of Tyr and CUR, thereby enhancing their bioavailability and therapeutic effects. The entrapment efficiencies of Tyr and CUR were obtained at 79.31 ± 5.
View Article and Find Full Text PDF